Nifedipin miometrium relaxálo hatásának vizsgálata terbutalin és K+-csatorna gátlók jelenlétében in vitro

Translated title of the contribution: Investigation of uterus-relaxing effects of nifedipine in the presence of terbutaline and K+-channel blockers

Judit Hajagos-Tóth, Zsolt Kormányos, G. Falkay, A. Pál, R. Gáspár

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Tocolysis is one of the greatest challenges in obstetrical practice. It is known that the calcium channel antagonists abolish the intracellular calcium ion transients and myometrial contraction. However there is a growing interest in experimental studies to use different tocolytic combination. The aims of the study were to investigate the effects of nifedipine on potassium chloride (KCl)-evoked rat uterine contractions on the last day of pregnancy (22) in vitro, and the alterations in the effects of nifedipine on combination with BKCa-channel blockers paxillin and tetraethyl ammonium chloride in late pregnancy in vitro. An other aim was to investigate the modification of the effect of nifedipine by terbutaline on the contraction of isolated rat and human myometrium. For human myometrial rings rhythmic contractions were evoked with oxytocin in an isolated organ bath. KCl-stimulated uterine contractions were inhibited concentration-dependently by nifedipine. In the presence of the potassium channel blockers, the action of nifedipine was not modified. Synergism was observed in the uterus-relaxing effect of nifedipine and terbutaline, though the extent of potentiation depended on the sequence of the administration of the two compounds. When terbutaline was added first in a single dose, the maximal inhibitory effect of nifedipine was lower. This decrease in the inhibition was suspended by a Ca2+-poor buffer, indicating the role of Ca2+ channel activating effect of terbutaline. However, in the isolated organ bath studies the BKCa channel had no effect on the uterus relaxing effect of nifedipine in spite of literature [1]. Conclusion: It is concluded that the combination of nifedipine and β2-agonists should be considered for clinical use. However, the administration of terbutaline can not precede the administration of nifedipine.

Original languageHungarian
Pages (from-to)109-114
Number of pages6
JournalActa Pharmaceutica Hungarica
Volume80
Issue number3
Publication statusPublished - 2010

Fingerprint

Terbutaline
Nifedipine
Uterus
Uterine Contraction
Baths
Potassium Channel Blockers
Tocolytic Agents
Paxillin
Tocolysis
Ammonium Chloride
Pregnancy
Potassium Chloride
Myometrium
Calcium Channel Blockers
Oxytocin
Buffers
Ions
Calcium

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Nifedipin miometrium relaxálo hatásának vizsgálata terbutalin és K+-csatorna gátlók jelenlétében in vitro. / Hajagos-Tóth, Judit; Kormányos, Zsolt; Falkay, G.; Pál, A.; Gáspár, R.

In: Acta Pharmaceutica Hungarica, Vol. 80, No. 3, 2010, p. 109-114.

Research output: Contribution to journalArticle

@article{607ec71687b2454db23be0102a7bb1e3,
title = "Nifedipin miometrium relax{\'a}lo hat{\'a}s{\'a}nak vizsg{\'a}lata terbutalin {\'e}s K+-csatorna g{\'a}tl{\'o}k jelenl{\'e}t{\'e}ben in vitro",
abstract = "Tocolysis is one of the greatest challenges in obstetrical practice. It is known that the calcium channel antagonists abolish the intracellular calcium ion transients and myometrial contraction. However there is a growing interest in experimental studies to use different tocolytic combination. The aims of the study were to investigate the effects of nifedipine on potassium chloride (KCl)-evoked rat uterine contractions on the last day of pregnancy (22) in vitro, and the alterations in the effects of nifedipine on combination with BKCa-channel blockers paxillin and tetraethyl ammonium chloride in late pregnancy in vitro. An other aim was to investigate the modification of the effect of nifedipine by terbutaline on the contraction of isolated rat and human myometrium. For human myometrial rings rhythmic contractions were evoked with oxytocin in an isolated organ bath. KCl-stimulated uterine contractions were inhibited concentration-dependently by nifedipine. In the presence of the potassium channel blockers, the action of nifedipine was not modified. Synergism was observed in the uterus-relaxing effect of nifedipine and terbutaline, though the extent of potentiation depended on the sequence of the administration of the two compounds. When terbutaline was added first in a single dose, the maximal inhibitory effect of nifedipine was lower. This decrease in the inhibition was suspended by a Ca2+-poor buffer, indicating the role of Ca2+ channel activating effect of terbutaline. However, in the isolated organ bath studies the BKCa channel had no effect on the uterus relaxing effect of nifedipine in spite of literature [1]. Conclusion: It is concluded that the combination of nifedipine and β2-agonists should be considered for clinical use. However, the administration of terbutaline can not precede the administration of nifedipine.",
keywords = "β-mimetics, B, Channel blockers, Nifedipine, Pregnancy",
author = "Judit Hajagos-T{\'o}th and Zsolt Korm{\'a}nyos and G. Falkay and A. P{\'a}l and R. G{\'a}sp{\'a}r",
year = "2010",
language = "Hungarian",
volume = "80",
pages = "109--114",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "3",

}

TY - JOUR

T1 - Nifedipin miometrium relaxálo hatásának vizsgálata terbutalin és K+-csatorna gátlók jelenlétében in vitro

AU - Hajagos-Tóth, Judit

AU - Kormányos, Zsolt

AU - Falkay, G.

AU - Pál, A.

AU - Gáspár, R.

PY - 2010

Y1 - 2010

N2 - Tocolysis is one of the greatest challenges in obstetrical practice. It is known that the calcium channel antagonists abolish the intracellular calcium ion transients and myometrial contraction. However there is a growing interest in experimental studies to use different tocolytic combination. The aims of the study were to investigate the effects of nifedipine on potassium chloride (KCl)-evoked rat uterine contractions on the last day of pregnancy (22) in vitro, and the alterations in the effects of nifedipine on combination with BKCa-channel blockers paxillin and tetraethyl ammonium chloride in late pregnancy in vitro. An other aim was to investigate the modification of the effect of nifedipine by terbutaline on the contraction of isolated rat and human myometrium. For human myometrial rings rhythmic contractions were evoked with oxytocin in an isolated organ bath. KCl-stimulated uterine contractions were inhibited concentration-dependently by nifedipine. In the presence of the potassium channel blockers, the action of nifedipine was not modified. Synergism was observed in the uterus-relaxing effect of nifedipine and terbutaline, though the extent of potentiation depended on the sequence of the administration of the two compounds. When terbutaline was added first in a single dose, the maximal inhibitory effect of nifedipine was lower. This decrease in the inhibition was suspended by a Ca2+-poor buffer, indicating the role of Ca2+ channel activating effect of terbutaline. However, in the isolated organ bath studies the BKCa channel had no effect on the uterus relaxing effect of nifedipine in spite of literature [1]. Conclusion: It is concluded that the combination of nifedipine and β2-agonists should be considered for clinical use. However, the administration of terbutaline can not precede the administration of nifedipine.

AB - Tocolysis is one of the greatest challenges in obstetrical practice. It is known that the calcium channel antagonists abolish the intracellular calcium ion transients and myometrial contraction. However there is a growing interest in experimental studies to use different tocolytic combination. The aims of the study were to investigate the effects of nifedipine on potassium chloride (KCl)-evoked rat uterine contractions on the last day of pregnancy (22) in vitro, and the alterations in the effects of nifedipine on combination with BKCa-channel blockers paxillin and tetraethyl ammonium chloride in late pregnancy in vitro. An other aim was to investigate the modification of the effect of nifedipine by terbutaline on the contraction of isolated rat and human myometrium. For human myometrial rings rhythmic contractions were evoked with oxytocin in an isolated organ bath. KCl-stimulated uterine contractions were inhibited concentration-dependently by nifedipine. In the presence of the potassium channel blockers, the action of nifedipine was not modified. Synergism was observed in the uterus-relaxing effect of nifedipine and terbutaline, though the extent of potentiation depended on the sequence of the administration of the two compounds. When terbutaline was added first in a single dose, the maximal inhibitory effect of nifedipine was lower. This decrease in the inhibition was suspended by a Ca2+-poor buffer, indicating the role of Ca2+ channel activating effect of terbutaline. However, in the isolated organ bath studies the BKCa channel had no effect on the uterus relaxing effect of nifedipine in spite of literature [1]. Conclusion: It is concluded that the combination of nifedipine and β2-agonists should be considered for clinical use. However, the administration of terbutaline can not precede the administration of nifedipine.

KW - β-mimetics

KW - B

KW - Channel blockers

KW - Nifedipine

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=78449306310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449306310&partnerID=8YFLogxK

M3 - Article

C2 - 21222320

AN - SCOPUS:78449306310

VL - 80

SP - 109

EP - 114

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 3

ER -